PT-141 (Bremelanotide) Reconstitution, Storage and Handling for Laboratory Research
RESEARCH PT-141 (Bremelanotide) Reconstitution, Storage and Handling for Laboratory Research PT-141, known chemically as bremelanotide, requires precise handling of its lyophilized state to maintain molecular integrity during laboratory analysis. Proper storage and solvent selection are critical requirements for researchers maintaining the stability of this synthetic peptide in controlled study environments. Compound identity: CAS 189691-06-3 · C50H68N14O10 · 1025.2 g/mol (verified via PubChem)
The Chemistry of Bremelanotide
Bremelanotide is a synthetic cyclic heptapeptide lactam analog of alpha-melanocyte-stimulating hormone (α-MSH) [1]. In its lyophilized powder form, the compound is highly sensitive to environmental stressors that can lead to degradation or loss of structural conformation. Research settings must account for the peptide’s inherent susceptibility to hydrolysis and oxidation when exposed to moisture or fluctuating temperatures. Because bremelanotide functions as a melanocortin receptor agonist, the precision of the research material is paramount; even minor degradation can alter the binding affinity in receptor-based assays [1].
Lyophilized Handling and Solvent Selection
The handling of lyophilized peptides begins with the preservation of the vacuum seal. The powder is typically stored in a desiccated state to prevent the ingress of atmospheric moisture, which acts as a catalyst for peptide breakdown. When selecting a solvent for reconstitution in a laboratory setting, researchers must prioritize chemical compatibility. While sterile water or saline are common in clinical pharmacokinetic studies [1], laboratory protocols often require specific buffer systems to maintain the pH stability of the peptide. The objective is to achieve complete dissolution without inducing shear stress or thermal degradation, which can compromise the integrity of the cyclic structure.
Thermal Sensitivity and Cold-Chain Integrity
Temperature control is the primary defense against the denaturation of bremelanotide. The RECONNECT phase 3 trials evaluated the efficacy and safety of bremelanotide in clinical populations, but did not report specific stability profiles or thermal sensitivity data for the compound [2]. Repeated freeze-thaw cycles are detrimental to peptide research, as the transition between states can lead to aggregation and the formation of insoluble particulates. The FDA-approved prescribing information for bremelanotide specifies storage conditions for the finished drug product, but does not provide stability data for reconstituted laboratory-grade peptide [1]. For long-term storage of the lyophilized powder, deep-freeze conditions (often -20°C or lower) are standard to ensure the peptide remains within the specifications required for high-fidelity research.
Light Sensitivity and Oxidation
Bremelanotide is known to be sensitive to photo-oxidation. Exposure to ultraviolet (UV) and even ambient laboratory light can trigger photochemical reactions that alter the peptide’s chemical structure. Researchers should store vials in opaque containers or amber-colored glass to mitigate light-induced degradation. Furthermore, the presence of oxygen in the headspace of a vial can lead to the oxidation of sensitive residues. High-quality research materials are often packaged under an inert gas, such as nitrogen or argon, to displace oxygen and extend the shelf life of the compound prior to the initiation of experimental procedures.
Lot Tracking and Quality Assurance
The validity of any experimental outcome is inextricably linked to the quality of the starting material. In professional research, lot tracking is not merely a bureaucratic requirement; it is a scientific necessity. Every vial, whether containing 10mg or 100mg of material, must be cross-referenced with a Certificate of Analysis (COA) provided by the manufacturer. This document outlines the purity levels, typically verified through High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS). Researchers must confirm that the purity meets the threshold required for their specific assay—be it in-vitro receptor binding or animal model pharmacodynamics—to ensure that observed effects are attributable to bremelanotide rather than synthesis impurities or degradation products [1][2].
Frequently asked questions
What is the recommended storage temperature for lyophilized PT-141? Lyophilized bremelanotide should be stored in a cool, dry environment. The FDA-approved prescribing information for bremelanotide specifies storage conditions for the finished drug product, but does not define specific long-term or short-term storage protocols for laboratory-reconstituted peptide [1]. Does the vial quantity (e.g., 10mg) affect the storage requirements? The FDA-approved prescribing information for bremelanotide does not address how vial quantity affects storage requirements for laboratory-grade material [1]. Can PT-141 be refrozen after reconstitution? The FDA-approved prescribing information for bremelanotide does not provide data regarding the effects of repeated freeze-thaw cycles on the compound [1]. How do researchers verify the purity of their research material? Researchers verify material quality by reviewing the Certificate of Analysis (COA) provided with the lot. This document details the results of HPLC and MS testing, which confirm the chemical identity and purity percentage of the peptide [1][2]. Why is light exposure a concern for peptide storage? Bremelanotide is susceptible to photo-oxidation. Exposure to light can catalyze reactions that degrade the peptide, potentially rendering the material unsuitable for research purposes [1]. What is the significance of the cyclic structure of bremelanotide? The cyclic heptapeptide structure is essential to the compound's pharmacological activity as a melanocortin receptor agonist [1]. Maintaining this specific conformation is the primary goal of all storage and handling protocols, as any structural change typically results in a loss of binding affinity [1][2]. Research use only. The compounds discussed are supplied for laboratory research and are not for human or veterinary use. Nothing on this page is medical advice, a dosing guide, or a claim about any product sold here; it summarises published research and cites its sources.
References
Authoritative sources cited for research context. Research use only — not medical advice.
